24 T-cell engager experience in SLE

Explain that early use of rituximab/b-cell depletion may substantially reduce the steroid requirement for many SLE patients .Explain the potential advantage of a fully humanised B-cell depleting agent

Authors

Institutions

Publication Details

Journal
Abstracts
Published
2025-10-01
DOI
https://doi.org/10.1136/lupus-2025-la.24
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

24 T-cell engager experience in SLE

Gerhard Krönke
Abstracts
CAR-T cell therapy research
article

24 T-cell engager experience in SLE

Gerhard Krönke
article en

Abstract

Explain that early use of rituximab/b-cell depletion may substantially reduce the steroid requirement for many SLE patients .Explain the potential advantage of a fully humanised B-cell depleting agent

Abstracts
Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 62%
CAR-T cell therapy research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

24 T-cell engager experience in SLE — Gerhard Krönke · Abstracts (2025) | TGRS Research Map | TGRS